ARCHIVES

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 10 | March 8, 1985

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008